Agrowing quantity of approvals and launches of new perfusion systemsare driving the growth of the.The increasing investment by major keyplayers available in the market is again fostering the growth of themarket. As an example, in January 2018, Miracor Medical Systems GmbH(Miracor Austria) and Miracor Medical SA (Miracor Medical) raisedaround US$ 26.3 Mn as part of a Series D financing round. The raisedamount is going to be utilized in the development andcommercialization of PiCSO Impulse System. Moreover, the growingdemand for organ transplants is further anticipated to accelerate thegrowth of the perfusion system market. In line with the datapublished by the National Kidney Foundation at the time of 2016,around 100,791 people in the U.S. are looking forward to kidneytransplants.
NorthAmerica is expected to hold a dominant position in the globalPerfusionSystem Marketowing to a growing partnership among key players. For instance, in2017, Paragonixc Technologies, Inc. entered into a strategicdistribution agreement with MBA Medical to market ParagonixTechnologies’ SherpaPak Cardiac and Kidney Transport Systems, inthe Southern part of the U.S.
XVIVOPerfusion AB, Organ Assist B.V., Paragonix Technologies, Inc., OrganRecovery Systems, Organ Transport Systems, Waters Medical Systems,TransMedics, Inc., OrganOx Limited, and Bridge to Life Ltd. are anumber of the key players in the market.
InMarch 2018, Sartorius Stedim Biotech SA launched its new ambr 250high throughput (ht) perfusion, a brand new automated parallelbioreactor system.
Read More@https://bit.ly/3CgpNLO
